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Lipopolysaccharide (LPS) has been implicated as one of the major cause of 
Gram-negative bacteria-induced sepsis that are life-threatening syndromes occurring in 
intensive care unit patients. Many natural products derived from medicinal plants may 
contain therapeutic values on protecting endotoxemia-induced sepsis by virtue their 
ability to modulate multiple pro-inflammatory cytokines. In the present study, we show 
that Salvia Miltiorrhiza (SM) BUNGE or Danshen, used in treatment of various 
systemic and surgical infections in the hospitals of China, was able to block the lethal 
toxicity of LPS in mice via suppression of TNF-α release and protection on liver injury. 
The ability of SM to suppress LPS-induced TNF-α release is further confirmed by in 
vitro experiments conducted on human peripheral blood leukocytes (PBL) and the 
RAW 264.7 macrophage cell line. Immunophenotyping by flow cytometry shows 
improved T-helper cell (CD4) and T-suppressor cells (CD8) ratio in SM-treated PBL 
and splenocytes of LPS-challenged mice. The drop in plasma glutamate-pyruvate 
transaminase (GPT) induced by LPS provides evidence that SM can protect hepatic 
damage. The present study explains some known biological activities of SM, and 
supports the clinical application of SM in the prevention of inflammatory diseases 
induced by Gram-negative bacteria. 
 
 




Gram-negative bacteria-induced sepsis often contributed to the large percentage of 
deaths occurs in hospitalized patients [1]. Most of the toxic manifestations induced by 
Gram-negative bacteria are caused by lipopolysaccharide (LPS); an endotoxin derives 
from the cell wall of Gram-negative bacteria, which is the component of the outer 
membranes of these organisms. The pathological manifestations attributed to LPS 
include circulatory shock, disseminated intravascular coagulation, and failure of 
numerous organs, including the central nervous system, heart, kidneys, gastrointestinal 
tract, lungs and liver [2-5]. Excessive release of proinflammatory cytokines including 
tumor necrosis factor alpha (TNF-α), interleukin 1 (IL-1), gamma interferon (IFN-γ) 
from the stimulated monocytes and tissue macrophages is said to be responsible for 
many of the pathological responses induced by LPS [4,6,7]. 
Antibiotic therapy does not prevent the toxic manifestations of LPS, and may even 
promote the release of LPS from bacteria [8,9].  Several clinical trails conducted with 
antagonists to TNF-α [10] failed to produce significant therapeutic benefits for septic 
patients partly because sepsis is not the result of the release of any one cytokines. 
Recent studies show that some natural products derived from medicinal plants may 
contain therapeutic values on protecting endoxemia-induced sepsis due to their ability 
to modulate multiple proinflammatory cytokines. Among the medicinal plants, 
anti-inflammatory substances derived cinnamon bark [11], biscoclaurine alkaloid 
cepharanthin [12] and naringin [13] have all been shown to be capable of blocking 
TNF-α release and the lethal shock induced by LPS. In attempt to search for natural 
components with protective properties of gram-negative bacterial infection, we have 
demonstrated that Salvia miltiorrhiza (SM) is also capable of suppressing the 
endotoxemia induced by LPS via suppression of TNF-α release and liver protection.  
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Salvia miltiorrhiza BUNGE or Danshen is officially listed in the Chinese 
Pharmacopenia and is best known for its unique application in the treatment of 
coronary heart diseases, hemorrhages, menstrual disorders and miscarriages, renal 
diseases, myocardial infarction and hypertension [14-17]. The protection of SM has 
been associated with its effects on cerebral edema, monoamines, neuropeptides, and 
neurotransmitter amino acids, thromboxane A2, peroxidation and downregulation of 
c-fos gene expression [18].  The plant is a rich source of polyphenols, with an excess of 
160 polyphenols has been identified [19,20]. The active constituents of SM can be 
classified into two groups. The first group consists of the phenolic compounds 
slavianolic acid and lithospermate B; and the second group consists of the abietane 
type-diterpene quinone pigments tanshinone I, tanshinone IIA, tanshinone IIB and the 
cryptotanshinone [19-21], rosmarinic acid and lithospermic acid [22]. The therapeutic 
effect of SM on heat stroke, myocardial ischemia and infarction has been largely 
attributed to the endothelium-dependent vasodilatory and hypertensive properties of 
the tanshinones [19-21] and lithospermic acid B [23]. The salvianoic acids A, B, and C 
of SM have also been shown to capable of protecting liver microsomes, hepatocytes 
and erythrocytes against oxidative damage [22] and recently showed to protect human 
neuroblastoma cells against cytotoxicity. Rosmarinic acid is a naturally occurring 
polyphenol with anti-oxidative and anti-inflammatory activities [25-27] and its salts are 
reported to have anti-HIV activities [28].   
SM or Danshen is frequently used as a decoction or intravenous injection in the 
treatment of various systemic and surgical infections in the hospitals of China. 
Successful outcomes have been observed in treating infections of hands and feet, 
erysipelas, ostemyelitis, matitis, cellulitis, otitis externa acute tonsillitis as well as 
infections of bone and joints but the anti-infection mechanistic actions have not been 
investigated. The present study sought to investigate the protective mechanisms of SM 
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on gram. By using an in vivo LPS-challenged mouse model, we have demonstrated that 
SM exhibits ant-inflammatory properties and suppressed the pro-inflammatory TNF-α 
cytokine release and liver damage induced by LPS in mice. The ability of SM to 
suppress LPS-induced pro-inflammatory TNF-α cytokine is further supported by the 
two separate in vitro experiments conducted with human peripheral blood leukocytes 
and macrophage RAW 264.7 cell line. The present study thus helps to explain some 
known therapeutic properties of SM.  
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MATERIALS AND METHODS 
 
Reagents 
The trade name of Salvia miltiorrhiza (SM) is H-care (batch no. 3HC1980808, 
supplied by Winsor Health Products Ltd., Hong Kong). Reagents for cell culture, 
TrizolTM, and PCR primers were purchased from Invitrogen (Carlsbad, Ca). 
Lipopolysaccharide (LPS) was purchased from Sigma (St. Louis, MO). ELISA kit for 
mouse TNF-α was purchased from Endogen (Woburn, MA). Anti-CD16/CD32, 
anti-CD3-fluorescein isothiocyanate (FITC), anti-CD4-phycoerythrin (PE), 
anti-CD8-PE antibodies, TMB substrate solution, ELISA kits for human TNF-α were 
supplied by PharMingen (San Diego, Ca). Buffy coats were obtained from Hong Kong 
Red Cross Blood Transfusion Service. Microplate reader was supplied by BioRad. 
The stock solution of Salvia miltiorrhiza was prepared by dissolving the dry SM 
capsule powder (10 mg/ml) in distilled water on a rolling plate for 30 minutes. The 
solution was centrifuged at 4,000 g for 20 minutes and the supernatant was further 
freeze-dried by Heto DryWinner (Denmark). The aqueous soluble fraction was 
collected after passing through a sterilized 0.22 μm filter.  
 
Mouse-treatment of SM and LPS 
Male BALB/c mice aged 6-8 wk were obtained from the animal house of the 
department of Zoology, the University of Hong Kong. All mice were kept at 22oC and 
55% relative humidity in a 12-hour day/night rhythm with free access to laboratory 
chow and water.  The mice were randomly divided into 2 groups of 12 animals and 
designated to receive orally either 0.3 ml of deionized water or SM (125 mg/kg/day) 
solution for a period of 38 days. The body weight of the animals was recorded every 
two days. After 38 days of oral feeding, half of the animals from each group received an 
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intraperitoneal injection of lipopolysaccharide (LPS) (20 mg/kg). The other half 
received 0.9% saline and was served as Control.  All experimental procedures were 
performed under license issued by the Government of Hong Kong SAR and endorsed 
by the Committee on the use of Live Animals in Teaching and Research of the 
University of Hong Kong. 
 
Biochemical analysis of blood samples in mouse 
After 24 hours of LPS injection, all mice were anesthetized with carbon dioxide and 
killed by exsanguination via heart puncture.  Blood were collected from the heart by 
using a 25-gauage syringe. The plasma was stored at 4°C until further analysis of 
TNF-α, lymphocyte subsets immunophenotyping and glutamate-pyurate transaminase 
(GPT) activity by ELISA, flow cytometry and spectrophotometry, respectively. 
 
Preparation of mouse peripheral blood leukocytes (PBL) and splenocytes 
Mouse peripheral blood leukocytes were isolated by using the red blood cell lysing 
buffer.  100 μl of blood sample was diluted (1:20) with red blood cell lysing buffer and 
placed at room temperature for 3 minutes. The mixture was centrifuged at 400 g for 5 
minutes and the supernatant was aspirated. The pellet contained the PBL was washed 
with phosphate buffer solution (PBS) and resuspended in 50 μl blocking buffer (PBS, 
1% BSA and 0.1% sodium azide) on ice.  
Splenocytes were prepared by dissociate the spleen in the cell strainer using a syringe 
plunger. The exudates were centrifuged at 400 g for 5 minutes and the red blood cells 
were removed by adding 2 ml of red blood cell lysing buffer. After washing with PBS, 
the splenocytes (1 x 106 cells) were resuspended in 50 μl blocking buffer on ice. 
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 Immunophenotyping of mouse peripheral blood leukocytes and splenocytes by 
flow cytometry 
Mouse PBL and splenocytes were pre-incubated with 0.5 μg of anti-CD16/CD32 
antibody for 15 minutes on ice to block the Fc receptors. Their lymphocyte subsets 
(total-T (CD3), T-helper/inducer (CD4) and T-cytotoxic/suppressor (CD8)) were 
immunophenotyped with monoclonal antibodies conjugated with fluorochromes. The 
anti-CD3 (total T subset) antibody was conjugated with fluorescein isothiocyanate 
(FITC); the other two antibodies (CD4 and CD8) were conjugated with phycoerythrin 
(PE).  Briefly, 20 μl of monoclonal antibody was added to the cell suspension and the 
mixture was incubated in the dark for 30 minutes. Before flow cytometric analysis, 400 
μl of blocking buffer was added to the mixture.  
 
Determination of glutamate-pyurate transaminase (GPT) activity in mouse serum  
To determine glutamate-pyurate transaminase (GPT) activity in serum, 100 μl of 
serum was mixed with 500 μl of preincubated (37°C) GPT substrate solution (1.8 mM 
α-ketoglutarate and 200 mM DL-alanine in 0.1 M phosphate buffer, pH 7.2) in test tube. 
The mixture was then incubated in a water bath at 37°C for 30 minutes. 500 μl of 1 mM 
2,4-dinitrophenylhydrazine (DNP) was added and the mixture was placed at room 
temperature for 20 minutes. Finally, 5 ml of 0.4 M NaOH was added and kept at room 
temperature for 5 minutes for color development. Absorbance of the mixture was 
measured at 505 nm. 
 
The in vitro treatment of LPS and SM on human peripheral blood 
leukocytes (PBL)  
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Fresh human PBLs were isolated buffy coats obtained from healthy blood donors. 
Briefly, PBLs were prepared by using red blood cell lysing buffer (NH4Cl 0.83%, 
NaHCO3 0.084%, EDTA 0.003%). The blood was diluted (1:45) with red blood cell 
lysing buffer and placed at room temperature for 3 minutes. Then the mixture was 
centrifuged at 400 g for 5 minutes. The supernatant was decanted and the cell pellet was 
resuspended and washed twice in complete RPMI 1640 medium. The cells were 
counted by Coulter Multisizer and seeded at a cell density of 2 x 105 cells per well in 96 
well tissue culture plates. The cells were treated with or without LPS (10 μg/ml) and 
SM (0, 100 and 400 μg/ml) for 72 hours.  Supernatant was collected at 72 hours for 
TNF-α detection by ELISA. 
 
In vitro treatment of Raw 264.7 macrophage cell line with LPS and SM 
The Raw 264.7 macrophage cell line (originally from the American Type Culture 
Collection) was kindly donated by Dr. R.C.C. Chang (The University of Hong Kong, 
HKSAR, China). The cells were grown in 25cm2 flasks in DMEM containing 10% heat 
inactivated fetal bovine serum, 100 U/ml penicillin/streptomycin and 1% fungizone at 
37°C in 5% CO2 incubator. For all experiments, cells were grown to ~80% confluence 
and were subjected to no more than 25 cell passages. The cells (5 x 106 cells/25cm2 
flasks) were pre-incubated with SM (0, 100 and 400 μg/ml) for 16 hours before 
exposed to LPS (1 μg/ml). Supernatant and cells were collected 3 hours after exposure 
to LPS for the detection of TNF-α by ELISA and RT-PCR. 
 
ELISA assay for TNF-α measurement 
Commercial ELISA kits for mouse/human TNF-α were used. The cytokine 
production was analyzed by sandwich ELISA. Briefly, ELISA plates were coated with 
appropriate capture antibodies diluted in sodium bicarbonate buffer (0.1M, pH 9.5) 
 9
overnight at 4°C. Plates were washed five times with washing buffer (0.05% Tween-20 
in PBS) between steps. The wells were blocked with 200 μl of assay diluents (10% FBS 
in PBS) for 3 hours at room temperature and 100 μl of supernatant or serum were added 
and incubated for 2 hours. Next, 100 μl of the working detector (detection antibody and 
avidin-horseradish peroxidase conjugate) was added and incubated for 1 hour at room 
temperature. Finally, color development was achieved by enzymatic reaction brought 
by incubation with 100 μl TMB substrate solution for 30 minutes and the reaction was 
terminated by adding 50 μl of 2 M sulphuric acid. The absorbance was measured on a 
microplate reader at 450 nm. 
 
Analysis of TNF-α mRNA levels in Raw 264.7 macrophage cell line by RT-PCR 
Total RNA was isolated from Raw264.7 cells according to the instructions of the 
manufacturer. Briefly, cells were lysed by adding 2 ml of TrizolTM to the flask. Total 
RNA concentration was measured by spectrophotometry (absorbance at 260nm and 
280nm). The RNA preparation was controlled by minigel agarose electrophoresis with 
visualization of the 18S and 28S ribosomal RNA bands after ethidium bromide staining. 
One μg of total RNA from each sample was reverse transcribed in 20 μl of a reaction 
buffer containing reverse transcriptase from murine leukemia moloney virus (M-MLV 
RT). For PCR, 1 μl of cDNA was amplified by PCR by using the following specific 
primers: 
Gene   Primer sequences (5’-------> 3’)   
TNF-α   GGC CTT CCT ACC TTC AGA CC   
            AGC AAA AGA GGA GGC AAC AA 
GAPDH                GGT GAA GGT CGG TGT GAA CG         
          GGT AGG AAC ACG GAA GGC CA 
The reaction mixtures of TNF-α and GAPDH were subjected to 30 cycles and 25 
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cycles denaturation (95°C, 3 min) respectively, annealing for 30 s at 60°C and 
extension for 30 s at 72°C. A final extension was 10 min at 72°C. The amplicons were 
visualized on a 1.5% ethidium bromide stained agarose gel. Intensities of band were 
compared after visualization on an UV transilluminator and analyzed by Image Master 
Total Lab (Amersham pharmacia biotech).  
 
Statistical analysis 
Statistical significance of the data was determined by one-way analysis of variances 
(ANOVA). Results were compared by Student’s paired t test with a two-tailed 




Protection of SM on LPS-induced body weight change  
Figure 1 shows that chroming feeding of SM did not affect the normal growth 
pattern of the animals throughout the feeding period. Thirty minutes post LPS injection, 
sign of reduced physical activities as well as shock symptoms such as bloody nose, 
anorexia and diarrhea were observed in all the animals. These classical pathological 
symptoms of LPS were however less apparent in animals with SM treatment.  The 
protective effect on LPS-induced toxicity is supported by the significant (p< 0.05) 
protection on the reduction of  body weight caused by LPS in the SM-treated mice as 
compared to the non-SM-treated animals. 
 
Suppression of SM on LPS-induced TNF-α level measured in mouse plasma, 
human peripheral blood leukocytes culture and Raw 264.7 macrophages. 
Since excessive release of the pro-inflammatory cytokine TNF-α is often associated 
with many of the pathological responses induced by LPS [7], we have detected its 
serum level 24 hours after LPS injection in the animals.  Figure 2 showed that the basal 
circulatory level of TNF-α in the control (non-LPS) mice was not affected by SM. 
Upon LPS challenge, the plasma level of TNF-α was enhanced by three-fold.  
LPS-induced elevation serum TNF-α in mice was significantly (p<0.05) reduced from 
146 pg/ml to 85 pg/ml with SM treatment.  
The ability of SM to reduce TNF-α release was further tested by carried out two 
independent in vitro experiments using different cells of the immune response.  Figure 
3 shows that the secretion of TNF-α was reduced (p< 0.01) by SM dose-dependently in 
both Control and LPS treated human peripheral blood leukocytes. At 100 μg/ml of SM, 
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the level of TNF-α reduced by 30% and 35% in the Control and LPS treated PBL, 
respectively. 
The ability of SM to suppress TNF-α  is further confirmed by the Raw264.7 
macrophages cell line. Figure 4A shows that only small amounts of TNF-α were 
detectable by the ELISA assay in the supernatant of the non-LPS treated Raw 264.7 
cells. Upon LPS challenge, the TNF-α level of the cultured macrophages cells (without 
SM treatment) was enhanced by three hundred-fold. SM at 100 μg/ml and 400 μg/ml 
dose level significantly suppressed the TNF-α release by 15% and 30%, respectively. 
Figure 4B presented the RT-PCR data indicating SM inhibits LPS-induced TNF-α 
release likely at the mRNA level. 
 
 
Elevation of CD4/CD8 ratio in spleen and peripheral blood mononuclear cells of 
LPS-treated mice by SM 
Challenging the BALB/c mice with LPS derived from Escherichia allowed us to 
assess both humoral and cell-mediated immune resistance. Immunophenotying by flow 
cytometry of both peripheral blood T-lymphocytes and splenocytes clearly illustrated 
that mice receiving SM treatment manifested a lower degree of injury upon LPS 
challenge. Following LPS challenge, the absolute lymphopenia of CD3+ lymphocytes 
was observed. Upon stimulation of LPS, there is usually a massive decline in CD4+ T 
helper cells with the CD8+ T cytotoxic cells either remain unchanged or elevated (Ertel 
and Faist, 1989). This leads to a conversion of the CD4/CD8 ratio to decrease 
dramatically.  In this study, we found that LPS induced similar changes in both 
T-lymphocytes (Table 1) and splenocytes (Table 2) as shown by a decrease in CD4+ 
and CD8+ cells accompanied by a decrease in the CD4/CD8 ratio.  
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Suppression of LPS-induced GPT Level by SM 
Plasma glutamate-pyruvate transaminase (GPT) level was used as an index of 
hepatotoxicity. Figure 5 shows that the plasma GPT level of the non-SM (Control) and 
SM fed healthy mice (SM) was similar. LPS induced an 8-fold increase of the liver 
GPT level in the non-SM treated mice and this elevation was significantly lowered with 
SM treatment.  The liver LPS-induced GPT elevation level was significantly lower in 
the SM treated mice (156.32 ± 1.45 unit) as compared to the non SM treated mice 




Endotoxin has been recognized as one of the major causes of Gram-negative 
bacteria-induced sepsis that are life-threatening syndromes occurring often in intensive 
care unit patients [3,29]. The pro-inflammatory cytokines tumor necrosis factor-α and 
interleukin–1α have been implicated as principal mediators during endotoxemia [6,30]. 
Infusion of high doses of these mediators results in severe tissue damage, organ failure 
and death [6,7]. TNF-α is regarded as the main executor of many deleterious effects of 
endotoxaemia and an important marker of severity in sepsis [29] and dysfunction 
[4,6,30]. 
Recently, Salvia miltiorrhiza BUNGE or Danshen attracts many scientists because 
of its many tanshinones and phenolic compounds exhibit diverse biological activities 
such as anti-inflammatory, anti-bacterial, antitumor, antioxidant, and anti-mutagenesis 
[16,29,31-35].  By using the LPS-induced endotoexomia animal model, this is the first 
report to reveal that the anti-inflammatory properties of SM involves suppression of the 
pro-inflammatory cytokine tumor necrosis factor alpha, improvement of T-cell 
immunity and protection of liver injury. The ability of SM to suppress LPS-induced 
TNF-α release is further supported by its dose-dependent lowering effect observed with 
the isolated human peripheral blood leukocytes (Figure 3) and Raw264.1 macrophages 
cell line (Figure 4) in vitro.  To what extents the control of TNF-α release by SM 
contributed to the execution of the many deleterious effects of endotoxaemia observed 
in this study has yet to be determined. The inhibition on pro-inflammatory cytokine 
TNF-α activity, however, has been regarded as an important anti-atherosclerotic 
property of SM in treatment of acute coronary syndromes [36].  Both aqueous ethanolic 
extract (SME) and the water-soluble antioxidant, savianolic acid B (Sal B) of SM, have 
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been shown to inhibit TNF-α induction on nuclear factor kappa B (NF-κB) expression 
in human aortic endothelial cells (HAECs) line [37]. 
Immunophenotyping by flow cytometry of both peripheral blood leukocytes and 
splenocytes in mice illustrated for the first time that SM can play an important role in 
cell-mediated immune resistance. Following endotoxin challenge, the absolute 
lymphopenia of CD3+ lymphocytes was observed. In both splenocytes and 
T-lymphocytes, the helper cell (CD4+) and suppressor cell (CD8+) populations were 
greatly reduced after LPS treatment with the CD4+ population decreased in a greater 
extent than CD8+. The absolute percentages of lymphocyte subsets from spleen and 
blood were slightly different and their response to SM treatment was not identical.  On 
the whole, SM improved the CD4+/CD8+ ratio; and this ratio of lymphocytes in the 
blood were more sensitive to both LPS and SM than that of the spleen. 
The mechanism(s) by which SM protects LPS-induced deletion of the T-helper cells 
(CD4) observed in this study is unknown. Deletion of T-lymphocytes is often resulted 
from programmed cell death caused by several adverse conditions such as ligation of 
Fas/APO-1/CD95, CD30, TNF receptor, and cytotoxic T lymphocyte antigen on T cells 
[38]. On one hand, the lymphocytes require to receive the corresponding signals to 
mount a productive immune response such as to produce cytotoxic T-cells (CD8) to 
destroy antigen-bearing target or secrete soluble cytokines.  On the other hand, failure to 
provide the proper signals could either abort or imbalance such immune response. 
Among the many active components, both rosmarinic acid and tanshinones of SM are 
likely candidates. It has been suggested that rosmarinic acid can affect the mediation of 
T-cells through suppression on the inflammatory eicosanoids and free radicals, both of 
which have been showed to inhibit lymphocyte proliferation [39,40]. At concentrations 
of 10-5-10-3M [26], rosmarinic acid has been shown to inhibit the formation of the 
inflammatory eicosanoids such as the 5-hyroxy-6, 8, 11, 14-eicosatetraenoic acid 
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(5-HETE) and leukotriene B4 (LTB4) (5-lipooxygenase products).  Rosmarinic acid has 
been considered as a new inhibitor of complement C3-convertase with 
anti-inflammatory activity [25].  It can inhibit cytokine-induced proliferation of murine 
mesangial cells and suppress c-myc mRNA expression in PDGF-stimulated mesangial 
cells [27]. The tanshinones and crypotanshinone of SM, on the other hand, can favor the 
T-cell specific immune defense of the mice either by promoting differentiation or 
rescuing deletion of the T-helper cells (CD4), or both, via suppression of LPS-induced 
nitric oxide (NO) production. NO is synthesized via the oxidation of arginine, by a 
family of nitric acid synthases (NOS), and plays a vital role in apoptotic cell death 
pathways of LPS. Several tanshinones and crypotanshinone have been shown to be 
capable of reducing LPS-induced NO production and interfering with the expression of 
the molecular target genes NOS, NF-κB, and ERK that are involved in the apoptotic 
signaling pathway of LPS in the Raw 264.7 macrophages [41,42].  
The glutamate-pyruvate transaminase (GTP) is a cytosolic enzyme of the liver cells. 
The increase plasma level of GTP is often associated with hepatic necrosis [43-45] and 
the cell death process is accompanied by plasma membrane permeability increase 
[46-49]. Oral feeding of SM had no adverse effect on the plasma glutamate-pyruvate 
transaminase of the healthy animals. LPS challenge significantly elevated a 4-fold 
increase of the GPT activity as compared to the control. SM reduced LPS-induced GPT 
elevation and a 275 SF unit/ml detected difference was observed between the SM-treated 
and non SM-treated mice. The reduction of GPT by SM indicates its protective potential 
on liver injury.  In recent finding, it has been shown that SM is capable of protecting liver 
fibrosis via its ability to suppress many of the fibrosis-related genes including the 
α-smooth muscle growth factor, connective tissue growth factor, and tissue inhibitor of 
metalloproteinase-1 [35]. The protection of lipopolysaccharide-induced hepatic damage 
has been demonstrated by other medicinal plant components including edaravone [43], 
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gentiopicroside [50], Hibiscus protocatechuic acid [51]. Their common mechanisms are 
suppression of the inflammatory cytokine and reduction in necrosis of the liver caused by 
the oxidative stress. Whether SM protected LPS-induced liver damage was via its 
scavenging effect on superoxide and inhibition on TNF-α release remains to be 
determined.  
In conclusion, the information provided in the current study helps to explain some of 
the clinical benefits of Salvia miltiorrhiza (commercial name H-care) observed during 
treatments of bacterial infection in hospitals. The anti-inflammatory mechanism of 
actions of SM includes modifying of both humoral immunity and non-specific immunity 
as well as alleviating hepatotoxicity. Further studies are, however, warranted to identify 
the individual active compounds that are responsible for the immunoregulatory activities 
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FIG. 1. Effect of Salvia Miltiorrhiza on mouse body weight. Male BALB/c mice 
were orally fed with or without Salvia Miltiorrhiza (SM) (125 mg/kg/day) for a total of 
39 days. On day-38, half of the animals received intraperitoneal injection of LPS (20 
mg/kg) and the other half received 0.9% saline. Data are mean ± SEM for twelve and 
six mice per group before and after day 39, respectively. * p<0.05 vs Control+LPS.  
 
FIG. 2. Effect of Salvia Miltiorrhiza on TNF-α expression in mouse peripheral 
blood leukocytes. Male BALB/c mice were orally fed with or without Salvia 
Miltiorrhiza (SM) (125 mg/kg/day) for 39 days. On day 38, half of the animals received 
intraperitoneal injection of LPS (20 mg/kg) and the other half received 0.9% saline. 
Peripheral blood leukocytes were isolated and their expression of TNF-α was 
determined by ELISA. Data are mean ± SEM for six mice/group. * p<0.001 as 
compared with Control group (no SM).  
 
FIG. 3. Effect of Salvia Miltiorrhiza on TNF-α expression in human peripheral 
blood leukocytes. Human peripheral blood leukocytes were treated with or without 
LPS (10 μg/ml) and Salvia Miltiorrhiza (SM) (0, 100 and 400 μg/ml) for up to 72 hours. 
Supernatants were collected and TNF-α expression was determined by ELISA. Data 
are mean ± SEM (n=12). *, ** p<0.05, 0.01, respectively as compared with 0 μg/ml of 
SM treatment. 
 
FIG. 4. Effect of Salvia Miltiorrhiza on TNF-α expression in Raw 264.7 
macrophages. Raw 264.7 macrophages were pre-incubated in the presence of Salvia 
Miltiorrhiza (SM) (0, 100 and 400 μg/ml) for 16 hours and subsequently treated with or 
 26
 27
without LPS (1 μg/ml). Cells and supernatants were collected at 3 hours after exposure 
to LPS. (A) TNF-α expression was determined by ELISA. Data are mean ± SEM (n=6). 
*, *** p<0.05, 0.001, respectively as compared with 0 μg/ml of SM treatment. (B) 
TNF-α expression was determined by RT-PCR and the amount of RNA loaded in each 
lane was confirmed by GAPDH mRNA.  
 
 
FIG. 5. Effect of Salvia Miltiorrhiza on mouse plasma level of glutamate-pyruvate 
transaminase. Male BALB/c mice were orally fed with or without Salvia Miltiorrhiza 
(SM) (125 mg/kg/day) for 39 days. On day 38, half of the animals received 
intraperitoneal injection of LPS (20 mg/kg) and the other half received 0.9% saline. 
Glutamate-pyruvate transaminase (GPT) level in serum was analyzed as mentioned in 
Materials and Methods. Data are mean ± SEM for six mice/group. * p< 0.001 as 













































































































































Table 1. Effects of Salvia miltiorrhiza on the mouse T-lymphocytes subpopulation challenged by LPS
Male BALB/c mice were orally fed with or without Salvia Miltiorrhiza (SM) (125 mg/kg/day) for 40 days. On day
38, half of the animals received intraperitoneal injection of LPS (20 mg/kg) and the other half received 0.9% saline.
Mouse peripheral blood leukocytes were isolated as described in Materials and Methods. Immunophenotype
determination was carried out by flow cytometry.
Data are mean ± SEM for six mice/group.
*p<0.05 vs Control group
1.89 ± 0.0417.38 ± 0.71 41.14 ± 3.03 5.74 ± 0.19
         CD8                CD4          CD4/CD8               CD8               CD4            CD4/CD8 
Control
Non-LPS LPS   Treatment
10.84 ± 0.452.36 ± 0.09
2.43 ± 0.14*13.95 ± 0.55SM 16.63 ± 0.60 46.49 ± 1.38 5.78 ± 0.27 2.80  ±  0.03
% Lymphocyte subset % Lymphocyte subset
Table 2. Effects of Salvia miltiorrhiza the mouse Splenocytes subpopulation challenged by LPS
Male BALB/c mice were orally fed with or without Salvia Miltiorrhiza (SM) (125 mg/kg/day) for 40 days.
On day 38, half of the animals received intraperitoneal injection of LPS (20 mg/kg) and the other half
received 0.9% saline. Mouse splenocytes were isolated as described in Materials and Methods.
Immunophenotype determination was carried out by flow cytometry.
Data are mean ± SEM for six mice/group.
***p<0.001 vs Control group
17.45 ± 0.50 30.02 ± 0.67 1.72 ± 0.03***SM 17.72 ± 1.35 33.72 ± 2.05 1.97 ± 0.04
1.29 ± 0.02Control 16.47 ± 0.70 33.54 ± 1.18 2.03 ± 0.02 19.63 ± 1.12 25.16 ± 0.78
      CD8                   CD4              CD4/CD8          CD8                   CD4             CD4/CD8  
Non-LPS LPS   Treatment
% Lymphocyte subset % Lymphocyte subset
